Trial
NCT05784844
Antimicrobial Revision in Persistent Febrile Neutropenia
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Febrile Neutropenia
Intervention
Meropenem
Why stopped
Study was never initiated or activated - Reason was lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19